Chicago Trust’s Guardant Health GH Stock Holding History

Chicago Trust’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$268K	Buy	+1,500	New	+$245K	0.04%	320

Other funds holding GH

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

AGF Management Toronto, Ontario, Canada $24.5B AUM 50.2% 1-Year Est. Return

Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Chicago Trust's GH Position: Q3 2026 in Review

Chicago Trust opened a new position in Guardant Health (GH) in Q3 2026: 1,500 shares worth $268K. The stake represents 0.04% of the portfolio and ranks #320 among its holdings.

278 funds tracked by Wall St. Rank hold GH as of Q3 2026.

Chicago Trust held 1,500 shares of Guardant Health worth $268K as of Q3 2026.
Guardant Health was a new Chicago Trust position in Q3 2026.
Guardant Health made up 0.04% of Chicago Trust's portfolio in Q3 2026, its #320 holding.
278 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on Chicago Trust's 13F filing for Q3 2026, filed 28 Oct 2026.